Skip to content
Biotechnology, Medical Health Aged Care

New smart bandage could heal and monitor wounds at the same time

RMIT University 2 mins read

Australian researchers have unlocked the possibility of creating smart wound dressings that enable real-time monitoring while also being able to deliver healing agents in one simple, scalable platform.  

Chronic wounds cause significant burdens on healthcare systems due to the complexities of continuous and changing care required. Smart wound dressings that monitor infection or deliver healing therapeutics have emerged as a solution, but combining both monitoring and healing functions into one dressing has proven complex, until now.  

Researchers at RMIT University created a method of embedding tiny, multi-functional nanomaterials — known as carbon dots — into hydrogel dressing that serve the dual functions of monitoring and treat wound.  

Carbon dots are biocompatible carbon-based nanoparticles that can be used to image and sense changes in a wound and combat wound inflammation as therapeutic artificial enzymes (nanozymes). 

This new type of smart wound patch will change colour when there is pH change in the wound caused by infection. The colour change can be easily read out by portable smart devices. When these infection signals are detected, the system automatically releases therapeutic nanozymes into the wound to promote healing. The release of these therapeutic nanozymes can also be manually triggered by applying gentle pressure to the dressing, allowing clinicians or patients to provide additional treatment if required. 

RMIT PhD candidate and study first author Nan Nan said the dual nature of this smart wound patch would support more timely and effective intervention from clinicians.  

“Being able to address potential infection at the earliest opportunity is critical to chronic wound management, making this real-time system a potential game-changer for healthcare,” she said. 

Nan said their system using multifunctional carbon dots also cuts down on the complexity that typically comes with constructing smart wound dressings.  

“Our fabrication process using medically ready materials, such as hydrogels, to embed carbon dots for wound dressing is easy and scalable, with strong potential for commercial translation,” she said.  

Collaborator and Senior Lecturer at RMIT’s School of Engineering, Dr Haiyan Li, said their innovation provided a promising and adaptive platform that overcame some of the barriers that have stopped smart wound dressings being brought to market.  

“Many smart wound dressings developed in research laboratories are difficult to translate into real clinical products because they rely on complex designs or expensive sensing systems,” she said. 

 “Our approach integrates sensing and dual-mode therapeutic functions into a single dressing with a simple, streamlined design, which helps address some of the key challenges that have previously limited commercial translation.” 

“Importantly, this work has defined concise design rules for future smart dressings.” 

Next steps 

These initial studies were done at the lab scale, with validation in appropriate in vivo wound models being a key future step.

Researchers are looking to partner up with industry to refine and scale up the technology and bring smart wound patches to market.  

Study lead and Senior Lecturer at RMIT’s School of Engineering, Dr Lei Bao says that next steps will focus on further biological testing and preparing the technology for real-world applications. 

“Our next step is to evaluate how this technology performs in more advanced biological models and to work with industry partners to refine the design for real clinical use,” she said. 

“Ultimately, our goal is to translate this research into practical smart wound dressings and integrate this smart platform into a digital health ecosystem, where the data from the patch is collected, analysed, and used to drive clinical decisions to advance chronic wound management.” 

The team used RMIT’s cutting-edge Micro Nano Research Facility and Microscopy and Microanalysis Facility to conduct this research. 

‘Carbon-dot nanozyme-empowered responsive hydrogels for smart wound dressing’ was published in Chemical Engineering Science (DOI: 10.1016/j.ces.2025.123225) 


Contact details:

Michael Quin

[email protected]

+61499 515 417

Media

More from this category

  • Medical Health Aged Care
  • 17/03/2026
  • 12:03
Monash University

New microlearning video series to support the safer use of psychotropic medications in residential aged care

Researchers at Monash University and Flinders University have launched a series of microlearning education videos designed to support safer, more appropriate use of psychotropic medications for people living with dementia and in residential aged care. The video series includes 12 short, practical modules (approximately 5-7 minutes each) covering key topics including initiation, monitoring and discontinuation of antipsychotics, antidepressants and benzodiazepines. The videos are the latest in a suite of practical resources designed to support translation of key recommendations and good practice statements from the Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and…

  • Finance Investment, Medical Health Aged Care
  • 17/03/2026
  • 10:25
Jane Morgan Management

NeuroScientific Biopharmaceuticals (ASX:NSB) Advances StemSmart(TM) Manufacturing Scale-Up as Phase 2 Crohn’s Disease Trial Preparations Progress

Perth, Australia – 17 March 2026 | NeuroScientific Biopharmaceuticals Limited (ASX:NSB) has reached an important development milestone with the commencement of the first technology transfer manufacturing run of its patented StemSmart™ mesenchymal stem cell (MSC) process at leading Australian cell therapy manufacturer Q-Gen Cell Therapeutics. The initiation of the manufacturing run represents a key step in the transfer of the StemSmart™ manufacturing process to a large-scale clinical contract manufacturer that is then capable of providing adequate supply for Phase 2 clinical trials and future commercialisation. Q-Gen Cell Therapeutics, located within the QIMR Berghofer Medical Research Institute in Brisbane, is one…

  • Contains:
  • Medical Health Aged Care
  • 17/03/2026
  • 09:58
Dementia Australia

New support for Australians impacted by CTE

Dementia Australia is proud to announce it has partnered with ConneCTErs Australia to expand the support available for people living with suspected or probable chronic traumatic encephalopathy (CTE) and their carers. As part of the federal government’s $12.4 million CTE Support and Prevention Program, Dementia Australia and ConneCTErs Australia will run a pilot program of support group sessions for people affected by CTE in 11 sites across Australia, including all major cities and select regional locations, as well as online. Dementia Australia CEO Professor Tanya Buchanan said Dementia Australia is excited to be working withConneCTErs Australia to deliver a program…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.